Public Policy Priorities

Advocating for a Greater Life Science Future

 
Access to Water
Access to Water

California experiences periods of prolonged drought conditions; as a result, mandatory water cutbacks have been implemented throughout the state. Biocom is in regular contact with stakeholders most affected by this crisis, including public water agencies and the State Water Resources Control Board. Biocom encourages publicizing programs beneficial to life sciences, such as the Guaranteed Water for Industry Program, and urges officials to consider alternative measures before implementing mandatory shutoffs to businesses. We also support water diversification, such as desalination and indirect potable reuse. Learn More

Agricultural and Industrial Biotech
Agricultural and Industrial Biotech

Biotechnology has revolutionized how we feed and fuel the world and is a driver of some of the most exciting advancements in agriculture and energy of the century. By supporting policies that promote the development and production of advanced biofuels, renewable chemicals and biobased products, and communicate science-based information to consumers relevant to health, safety, and nutrition, Biocom gives members a powerful voice in Washington, D.C. and an environment which supports agricultural and industrial biotechnology innovation.Learn More

Biomedical Research Funding
Biomedical Research Funding

Federal investment in biomedical research is essential to the development of new drugs, vaccines, and technologies by supporting breakthrough research happening across the nation and especially in California. In Fiscal Year 2016, funding from the National Institutes of Health (NIH) supported over 7,500 grants in California alone, helping universities, research institutes and small companies turn ideas into innovative products. Biocom’s policy team is relentless working to ensure the continuity of funding for the NIH as well as biodefense and pandemic research programs. Learn More

Community Choice Energy
Community Choice Energy

Regions throughout California are implementing or deciding whether to implement Community Choice Aggregation, or government-run energy utilities. Biocom has concerns about fees governments pay to private utilities for breaking long-term contracts, and about the ability of CCAs to invest in new renewable energy infrastructure. We support thorough investigation into all costs and benefits before implementation of CCAs.

Construction and Development
Construction and Development

Biocom opposes implementation of new fees and taxes that hinder development of new life sciences facilities and campuses. In San Diego, the affordable housing offset, or “linkage fee,” was renegotiated in 2014; we successfully lobbied for an exemption for research and development from the 100% fee increase experienced by other industries. The City of Los Angeles is currently considering implementing a linkage fee of $3-5 per square foot for commercial development, depending on where the business is located. We urge officials to consider the potential negative impacts to businesses of all new fees before implementation.

Digital Health and Genomics
Digital Health and Genomics

Digital health has revolutionized our health care system by introducing technologies that allow for more efficient, targeted, and patient-centered approaches to the diagnostic and treatment of disease and delivery of care. As a result, Biocom staunchly supports policies that streamline the regulation and expand the reimbursement of digital apps and devices, remote patient monitoring technologies, and genomics products, as well as educational efforts that help patients, providers, and caregivers better understand the benefits and usage of these life-changing products. Learn More

FDA Regulatory Policy
FDA Regulatory Policy

Biocom is dedicated to improving the drug and device review and approval process, communication between industry and the Food and Drug Administration (FDA), and transparency and accountability within the agency. From advocating for continued funding for the agency and supporting industry-friendly legislation, to engaging on important regulatory matters and keeping members up-to-date, Biocom works with Congress, the FDA, and industry to create an environment that helps bring new treatments and cures to patients faster. Learn More

Gross Receipts Tax
Gross Receipts Tax

Gross receipts tax the total amount a company receives from all sources, without subtracting expenses or taking into account whether the company turns a profit. These taxes disproportionately affect companies with small margins like small and mid-sized life sciences. Biocom encourages regional governments to consider lowering or eliminating gross receipts taxes on the life sciences and/or companies that are not yet profitable.

Intellectual Property and Patent Law
Intellectual Property and Patent Law

Intellectual property is the lifeblood of the life science industry. Patents are so important to America’s prosperity that they have been enshrined in our Constitution as fundamental rights. Those rights have provided the foundation for a culture of innovation and entrepreneurship that has been an essential driver of our exceptional economic growth and global leadership. Biocom has vehemently opposed and will continue to oppose legislation that undermines those rights in any way, while supporting initiatives in Congress and at the Patent and Trademark Office (USPTO) that promote life science innovation. Learn More

Land Use
Land Use

Biocom prioritizes the preservation of Prime Industrial Lands (PIL) in San Diego for manufacturing and research and development to ensure member companies operate in environments conducive to regional long-term economic stability and industry growth. Biocom opposes discretionary approvals that remove PIL sites from the PIL land map and supports community plan updates that preserve Prime Industrial Lands, and prevent incompatible land uses by voting against collocated projects. We also work in other regions to expand areas in which life science companies are able to operate, and collaborate with other industries to ensure collation isn’t an issue. Learn More

Permits and Inspections
Permits and Inspections

Biocom supports efforts to make city and county permitting processes transparent and efficient. Insufficient inspector training, inconsistent standards, and understaffing can lead to unpredictable implementation of regulations. We work closely with government agencies to ensure proper training and enforcement. We appreciate efforts to ensure inspections are done consistently and in collaboration with businesses.Learn More

Regional Transportation
Regional Transportation

An efficient transportation system is an important part of business attraction and retention. Biocom supports a balanced approach to expansion of roadways and public transit to ensure that employees of our member companies have a variety of commuting options. We also work with elected officials to develop projects that alleviate traffic in areas where our member companies are concentrated. Learn More

Reimbursement and Patient Access To Care
Reimbursement and Patient Access To Care

Biocom is committed to ensuring that patients have access to the care they need and supports reimbursement policies that provide appropriate and inclusive coverage, coding, and payment for biopharmaceutical, medical device, diagnostic, and genomics products. Biocom has strongly opposed proposals that would cut reimbursement to physicians under Medicare Part B, impose rebates and price controls to Medicare Part D, and limit the availability of products through restrictive formularies, step therapy, and increased cost-sharing such as specialty tiers and high deductibles. Learn More

STEM Education and Workforce
STEM Education and Workforce

Biocom supports science, technology, engineering, and math (STEM) education in the United States to inspire the industry leaders of tomorrow and equip educators with the tools needed to prepare them. Through the Biocom Institute and dozens of annual programs, Biocom promotes the life sciences by creating opportunities for STEM students, teachers, scientists, and life science companies to work together and grow a diverse community of life science professionals. Biocom also supports immigration policies that provide American employers with greater access to the world’s best talents. Learn More

Storm Channel Maintenance
Storm Channel Maintenance

Flooding in the Sorrento Valley area of San Diego threatens the business activities of several Biocom member companies, especially those along Roselle Street. Floods cause physical damage to businesses and result in lost revenue when workers are evacuated. Biocom is working closely with the City of San Diego to develop a long-term plan to alleviate flooding in Sorrento Valley, and to ensure that the city keeps storm channels clear of debris so water can drain freely. Learn More

Sustainability
Sustainability

As a result of state legislation AB 32, cities throughout California are implementing Climate Action Plans to reduce greenhouse gas emissions. Biocom was involved in the development of San Diego’s Climate Action Plan, passed in 2015, and was instrumental in ensuring the plan included a requirement for cost benefit analysis of resulting regulations. We have also worked in other regions to increase awareness among our members about local Climate Action Plans, life science best practices related to sustainability, and corporate social responsibility.Learn More

Taxes
Taxes

Biocom is advocating for tax policies that promote research, innovation, and advanced manufacturing. A lower corporate tax code, territorial tax system, and incentives for high-risk industries would ensure that U.S. companies are successful at home and competitive abroad. Biocom also supports keeping the research and development tax credit permanent, repealing the medical device tax, and extending the orphan drug tax credit and renewable energy tax incentives. Learn More

 

Public Policy Newsletter

Members: Sign up to receive updates regarding the most important recent policy news.